A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients-Reference-Cited by-同舟云学术

A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients

Published:2019-08-07 Issue:2 Volume:178 Page:327-335
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Arnaout Angel,Robertson Susan J.,Pond Gregory R.,Lee Hoyun,Jeong Ahwon,Ianni Luisa,Kroeger Lynne,Hilton John,Coupland Stuart,Gottlieb Chloe,Hurley Bernard,McCarthy Anne,Clemons Mark^ORCID

Funder

Canadian Cancer Society

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-019-05381-y.pdf

Reference45 articles.

1. Levy JMM, Towers CG, Thorburn A (2017) Targeting autophagy in cancer. Nat Rev Cancer 17:528–542. https://doi.org/10.1038/nrc.2017.53

2. Zheng K, He Z, Kitazato K, Wang Y (2019) Selective autophagy regulates cell cycle in cancer therapy. Theranostics 9:104–125. https://doi.org/10.7150/thno.30308

3. Chude CI, Amaravadi RK (2017) Targeting autophagy in cancer: update on clinical trials and novel inhibitors. Int J Mol Sci 18(6):1279. https://doi.org/10.3390/ijms18061279

4. Papanagnou P, Papadopoulos GE, Stivarou T, Pappas A (2019) Toward fully exploiting the therapeutic potential of marketed pharmaceuticals: the use of octreotide and chloroquine in oncology. OncoTargets Ther 12:319–339. https://doi.org/10.2147/OTT.S182685

5. Zhang Y, Liao Z, Zhang L, Xiao H (2015) The utility of chloroquine in cancer therapy. Curr Med Res Opin 31:1009–1013. https://doi.org/10.1185/03007995.2015.1025731

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repurposing: a retrospective revolution in breast cancer medicine;Discover Medicine;2024-07-12

2. Pharmacology Progresses and Applications of Chloroquine in Cancer Therapy;International Journal of Nanomedicine;2024-07

3. Advances in the molecular regulation mechanism of tumor dormancy and its therapeutic strategy;Discover Oncology;2024-05-25

4. FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugs;Cellular & Molecular Biology Letters;2024-05-14

5. Targeting PNPO to suppress tumor growth via inhibiting autophagic flux and to reverse paclitaxel resistance in ovarian cancer;Apoptosis;2024-04-13